(IHI) iShares U.S. Medical - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US4642888105 • Health

IHI: Imaging Equipment, Artificial Limbs, Heart Devices, X-ray Equipment

The iShares U.S. Medical Devices ETF (NYSE ARCA: IHI) is designed to replicate the performance of the Dow Jones U.S. Select Medical Equipment Index, a benchmark for the U.S. medical equipment sector. The fund focuses on companies engaged in the development, manufacturing, and distribution of medical devices, including diagnostic equipment, surgical instruments, and implantable devices. Its portfolio includes a mix of large-cap and mid-cap companies, with a strong emphasis on firms that produce advanced medical technologies such as MRI machines, orthopedic implants, and cardiovascular devices. The ETF is non-diversified, meaning it can hold a higher concentration of its assets in a smaller number of securities, which may increase sector-specific risk but also allows for targeted exposure to the medical device industry.

Over the next three months, IHI is expected to maintain its upward trajectory, supported by strong fundamental demand for medical devices driven by an aging population and healthcare innovation. Technically, the funds short-term moving averages (SMA 20: 57.52) suggest recent momentum, while the SMA 50 (60.15) and SMA 200 (59.28) indicate a stable uptrend. The Average True Range (ATR: 1.61) points to moderate volatility, which may provide trading opportunities. With assets under management (AUM) of $4.315 billion, the fund benefits from ample liquidity and investor confidence in the medical device sector.

Additional Sources for IHI ETF

IHI ETF Overview

Market Cap in USD 4,492m
Category Health
TER 0.40%
IPO / Inception 2006-05-01

IHI ETF Ratings

Growth Rating 39.0
Fundamental -
Dividend Rating 46.6
Rel. Strength -2.34
Analysts -
Fair Price Momentum 52.59 USD
Fair Price DCF -

IHI Dividends

Dividend Yield 12m 0.46%
Yield on Cost 5y 0.66%
Annual Growth 5y 14.79%
Payout Consistency 81.7%

IHI Growth Ratios

Growth Correlation 3m -85.1%
Growth Correlation 12m 71.5%
Growth Correlation 5y 30.9%
CAGR 5y 7.80%
CAGR/Max DD 5y 0.24
Sharpe Ratio 12m 0.59
Alpha 0.27
Beta 0.624
Volatility 31.80%
Current Volume 496.6k
Average Volume 20d 632.7k
What is the price of IHI stocks?
As of May 01, 2025, the stock is trading at USD 59.79 with a total of 496,635 shares traded.
Over the past week, the price has changed by +3.64%, over one month by -0.66%, over three months by -6.20% and over the past year by +9.26%.
Is iShares U.S. Medical a good stock to buy?
Partly, yes. Based on ValueRay Analyses, iShares U.S. Medical (NYSE ARCA:IHI) is currently (May 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 38.98 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IHI as of May 2025 is 52.59. This means that IHI is currently overvalued and has a potential downside of -12.04%.
Is IHI a buy, sell or hold?
iShares U.S. Medical has no consensus analysts rating.
What are the forecast for IHI stock price target?
According to ValueRays Forecast Model, IHI iShares U.S. Medical will be worth about 58.9 in May 2026. The stock is currently trading at 59.79. This means that the stock has a potential downside of -1.49%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 58.9 -1.5%